The Congressional Budget Office publishes its predictions on the impact ACA’s repeal will have, concluding that premiums will spike and the number of people who are uninsured would increase by 18 million in the first coverage year following the repeal.
Theranos fails an inspection of its Scottsdale, AZ blood testing lab but fails to disclose this information to its investors.
The FDA launches the Innovation in Medical Evidence Development and Surveillance System, or IMEDS, which will make the FDA’s Sentinel System data and analytics tools available to private researchers.
In a New Yorker op-ed, Atul Gawande, MD compares the incremental approach primary care providers take in managing conditions with the one-and-done approaches surgeons prefer, conceding that primary care may be doing more good in the long run.
Reuters covers the use of data mining by health insurers to help price policies and target profitable customers more effectively.